Lack of association between tumor necrosis and hsp-27 expression in primary breast cancer

Journal of Surgical Oncology

Volumn 61, Issue 1, 1996, Pages 14-16

  Storm, F Kristian ^a,b   Mahvi, David M ^a   Gilchrist, Kennedy W ^a  

^a UNIVERSITY OF WISCONSIN   (United States)

^b University of Wisconsin Health   (United States)

Author keywords

breast cancer; heat shock protein 27; hsp 27; tumor necrosis

Indexed keywords

HEAT SHOCK PROTEIN;

ARTICLE; BREAST CANCER; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN LOCALIZATION; TISSUE DISTRIBUTION; TUMOR NECROSIS;

APOPTOSIS; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FEMALE; HEAT-SHOCK PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; NECROSIS; ODDS RATIO; RISK;

EID: 0030026259     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9098(199601)61:1<14::AID-JSO4>3.0.CO;2-V     Document Type: Article

References (17)

1. Chamness GC, Ruiz A, Fulcher L, et al.: Stress responsive protein srp-27 predicts recurrence in node-negative breast cancers. Breast Cancer Res Treat 12:130, 1988.
2. Tandon AK, Clark GM, Chamness GC, et al.: Clinical significance of heat-shock/stress-response proteins in breast cancer. Breast Cancer Res Treat 16:146, 1990.
3. Hurlimann J, Gebhard S, Gomez F: Oestrogen receptor, progesterone receptor, pS2, ERD5, HSP27 and cathepsin D in invasive ductal breast carcinomas. Histopathology 23:239-248, 1993.
4. Allred DC, Clark GM, Tandon AK, et al.: HER-2/neu in node-negative breast cancer: Prognostic significance of overexpression influenced by the presence of in situ carcinoma. J Clin Oncol 10:566-605, 1992.
5. Storm FK, Gilchrist KW, Warner TFCS, Mahvi DM: Distribution of hsp-27 and HER-2/neu in in situ and invasive ductal breast cancer. Ann Surg Oncol 2:43-48, 1995.
6. Storm FK, Tomic S, Gilchrist KW, et al.: Lack of correlation between hsp-27 expression and tumor grade or nodal status in infiltrating ductal carcinoma of the breast. (submitted).
7. Gilchrist KW, Gray R, Fowble B, et al.: Tumor necrosis is a prognostic predictor for early recurrence and death in lymph node positive breast cancer. A 10 year follow-up study of 728 ECOG patients. J Clin Oncol 11:1929-1935, 1993.
8. Adams DJ, Hajj H, Edwards DP, et al.: Detection of a Mw 24,000 estrogen-regulated protein in human breast cancer by monoclonal antibodies. Cancer Res 43:4297-4301, 1983.
9. Thor A, Benz C, Moore D, et al.: Stress resposne protein (srp-27) determination in primary human breast carcinomas: Clinical, histologic, and prognostic correlations. J Natl Cancer Inst 83:170-178, 1991.
10. Bishop YMM, Fienberg SE, Holland PW: "Discrete Multivariate Analysis: Theory and Practice." MIT Press, Cambridge, MA. 1975.
11. Carper SW, Duffy JJ, Gerner EW: Heat shock proteins in thermotolerance and other cellular processes. Cancer Res 47:5249-5255, 1987.
12. Ciocca DR, Steffi O, Chamness GC, et al.: Biological and clinical implications of heat shock protein 27000 (hsp-27): A review. J Natl Can Inst 85:1558-1570, 1993.
13. Ciocca DR, Adams DJ, Edwards DP, et al.: Distribution of an estrogen-induced protein with a molecular weight of 24,000 in normal and malignant human tissues and cells. Cancer Res 43:1204-1210, 1983.
14. Tetu B, Lacasse B, Bouchard H-L, et al.: Prognostic significance of hsp-27 expression in malignant fibrous histocytoma: A clinico-pathological and immunohistochemical study. Cancer Res 52:2325-2328, 1992.
15. Storm FK, Mahvi DM, Gilchrist KW: Hsp-27 is not expressed and has no prognostic significance in rectal adenocarcinoma. Reg Cancer Treat 3:146-148, 1993.
16. Storm FK, Mahvi DM, Gilchrist KW: Hsp-27 has no diagnostic or prognostic significance in prostate or bladder cancer. Urology 42:379-382, 1993.
17. Buja LM, Eigenbrodt ML, Eigenbrodt EH: Apoptosis and necrosis. Basic types and mechanisms of cell death. Arch Pathol Lab Med 117:1208-1214, 1993.